Integra Lifesciences Holdings Stock Fundamentals
| IART Stock | USD 29.38 0.40 1.38% |
Integra LifeSciences Holdings fundamentals help investors to digest information that contributes to Integra LifeSciences' financial success or failures. It also enables traders to predict the movement of Integra Stock. The fundamental analysis module provides a way to measure Integra LifeSciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Integra LifeSciences stock.
At this time, Integra LifeSciences' Net Income Applicable To Common Shares is comparatively stable compared to the past year. Net Income From Continuing Ops is likely to gain to about 75.5 M in 2024, whereas Total Operating Expenses is likely to drop slightly above 383.8 M in 2024. Integra | Select Account or Indicator |
Integra LifeSciences Holdings Company Profit Margin Analysis
Integra LifeSciences' Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current Integra LifeSciences Profit Margin | 0.04 % |
Most of Integra LifeSciences' fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Integra LifeSciences Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
| Competition |
Integra Pretax Profit Margin
Pretax Profit Margin |
|
Based on the latest financial disclosure, Integra LifeSciences Holdings has a Profit Margin of 0.0439%. This is 100.39% lower than that of the Health Care Equipment & Supplies sector and 100.8% lower than that of the Health Care industry. The profit margin for all United States stocks is 103.46% lower than that of the firm.
Integra LifeSciences Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Integra LifeSciences's current stock value. Our valuation model uses many indicators to compare Integra LifeSciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Integra LifeSciences competition to find correlations between indicators driving Integra LifeSciences's intrinsic value. More Info.Integra LifeSciences Holdings is rated third overall in return on equity category among related companies. It is rated second overall in return on asset category among related companies reporting about 1.06 of Return On Asset per Return On Equity. At this time, Integra LifeSciences' Return On Equity is comparatively stable compared to the past year.Comparative valuation analysis is a catch-all model that can be used if you cannot value Integra LifeSciences by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Integra LifeSciences' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Integra LifeSciences' earnings, one of the primary drivers of an investment's value.Integra Profit Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Integra LifeSciences' direct or indirect competition against its Profit Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Integra LifeSciences could also be used in its relative valuation, which is a method of valuing Integra LifeSciences by comparing valuation metrics of similar companies.Integra LifeSciences is currently under evaluation in profit margin category among related companies.
Integra Fundamentals
| Return On Equity | 0.0399 | ||||
| Return On Asset | 0.0424 | ||||
| Profit Margin | 0.04 % | ||||
| Operating Margin | 0.19 % | ||||
| Current Valuation | 3.64 B | ||||
| Shares Outstanding | 78.6 M | ||||
| Shares Owned By Insiders | 13.80 % | ||||
| Shares Owned By Institutions | 88.93 % | ||||
| Number Of Shares Shorted | 2.09 M | ||||
| Price To Earning | 26.94 X | ||||
| Price To Book | 1.62 X | ||||
| Price To Sales | 1.67 X | ||||
| Revenue | 1.54 B | ||||
| Gross Profit | 982.03 M | ||||
| EBITDA | 297.59 M | ||||
| Net Income | 67.74 M | ||||
| Cash And Equivalents | 451.52 M | ||||
| Cash Per Share | 5.41 X | ||||
| Total Debt | 1.68 B | ||||
| Debt To Equity | 1.03 % | ||||
| Current Ratio | 3.85 X | ||||
| Book Value Per Share | 20.31 X | ||||
| Cash Flow From Operations | 139.96 M | ||||
| Short Ratio | 2.27 X | ||||
| Earnings Per Share | 0.84 X | ||||
| Price To Earnings To Growth | 0.83 X | ||||
| Target Price | 44.4 | ||||
| Number Of Employees | 3.95 K | ||||
| Beta | 1.14 | ||||
| Market Capitalization | 2.28 B | ||||
| Total Asset | 3.78 B | ||||
| Retained Earnings | 946.86 M | ||||
| Working Capital | 751.06 M | ||||
| Current Asset | 438.5 M | ||||
| Current Liabilities | 139.13 M | ||||
| Net Asset | 3.78 B |
About Integra LifeSciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Integra LifeSciences Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Integra LifeSciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Integra LifeSciences Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 8.5 M | 5.3 M | |
| Total Revenue | 1.5 B | 1.6 B | |
| Cost Of Revenue | 653.2 M | 685.8 M | |
| Stock Based Compensation To Revenue | 0.01 | 0.01 | |
| Sales General And Administrative To Revenue | 0.54 | 0.57 | |
| Research And Ddevelopement To Revenue | 0.04 | 0.04 | |
| Capex To Revenue | (0.04) | (0.05) | |
| Revenue Per Share | 19.25 | 20.21 | |
| Ebit Per Revenue | 0.11 | 0.12 |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Integra LifeSciences Piotroski F Score and Integra LifeSciences Altman Z Score analysis. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Complementary Tools for Integra Stock analysis
When running Integra LifeSciences' price analysis, check to measure Integra LifeSciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Integra LifeSciences is operating at the current time. Most of Integra LifeSciences' value examination focuses on studying past and present price action to predict the probability of Integra LifeSciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Integra LifeSciences' price. Additionally, you may evaluate how the addition of Integra LifeSciences to your portfolios can decrease your overall portfolio volatility.
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |
Is Integra LifeSciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Integra LifeSciences. If investors know Integra will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Integra LifeSciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.60) | Earnings Share 0.84 | Revenue Per Share 19.248 | Quarterly Revenue Growth (0) | Return On Assets 0.0424 |
The market value of Integra LifeSciences is measured differently than its book value, which is the value of Integra that is recorded on the company's balance sheet. Investors also form their own opinion of Integra LifeSciences' value that differs from its market value or its book value, called intrinsic value, which is Integra LifeSciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Integra LifeSciences' market value can be influenced by many factors that don't directly affect Integra LifeSciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Integra LifeSciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Integra LifeSciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Integra LifeSciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.